Pfizer's XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma ...

Retrieved on: 2021-01-14 21:22:30

Tags for this article:

Click the tags to see associated articles and topics

Pfizer's XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma .... View article details on hiswai:

Excerpt

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) ...

Article found on: finance.yahoo.com